drugset / Trial / NCT00274118

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

NCT00274118

Phase 3 Completed 250 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindPrevention

Summary

To compare the renal consequences of two different approaches to blocking the renin angiotensin system in subjects with hypertension and concurrent Type II diabetes mellitus and diabetic nephropathy.

Timeline

Start
1997-07
Primary completion
2004-01
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified
Subject Telmisartan Other / unclassified